Imaging features, diagnosis, and clinical management of hepatic involvement in hereditary hemorrhagic telangiectasia: a case series report and literature review - Scorecard - MDSpire

Imaging features, diagnosis, and clinical management of hepatic involvement in hereditary hemorrhagic telangiectasia: a case series report and literature review

  • By

  • Qiubo Feng

  • Qinpan Rao

  • Jiaqi Duan

  • Shufeng Fan

  • Linying Ma

  • July 13, 2026

Share

Clinical Scorecard: Imaging Characteristics, Diagnosis, and Management Strategies for Hepatic Involvement in Hereditary Hemorrhagic Telangiectasia: A Case Series and Review of the Literature

At a Glance

CategoryDetail
ConditionHereditary Hemorrhagic Telangiectasia (HHT) with hepatic involvement
Key MechanismsCharacterized by diffuse hepatic arteriovenous malformations and telangiectasias
Target PopulationPatients diagnosed with HHT, particularly those with hepatic manifestations
Care SettingClinical and radiological evaluation in a hospital setting

Key Highlights

  • HHT is an autosomal dominant disorder with a global incidence of 1 in 5,000 to 1 in 8,000.
  • Diagnosis relies on the Curaçao criteria, requiring three or more criteria for a definite diagnosis.
  • Imaging modalities include Doppler ultrasound, CT, MRI, and DSA, each with distinct advantages.
  • Hepatic involvement can lead to serious complications such as portal hypertension and high-output heart failure.
  • Transcatheter hepatic arterial embolization carries a high risk of portal vein thrombosis.

Guideline-Based Recommendations

Diagnosis

  • Utilize the Curaçao criteria for diagnosing HHT.
  • Employ multimodal imaging for accurate diagnosis and characterization of hepatic involvement.

Management

  • Symptomatic treatment for complications such as heart failure.
  • Avoid routine application of hepatic arterial embolization without strict adherence to guidelines.

Monitoring & Follow-up

  • Regular follow-up examinations to assess treatment outcomes and complications.

Risks

  • High risk of misdiagnosis as liver cirrhosis or common hepatic arteriovenous fistulas.
  • Potential complications from interventional procedures, including portal vein thrombosis.

Patient & Prescribing Data

Patients with HHT presenting with hepatic involvement and related complications.

Symptomatic management is crucial, and careful evaluation is needed before interventional procedures.

Clinical Best Practices

  • Strengthen medical history collection to reduce misdiagnosis.
  • Implement multimodal imaging evaluation for comprehensive assessment.

Related Resources & Content

Original Source(s)

Related Content